Image may be NSFW.
Clik here to view.
Clik here to view.
U.S. Food and Drug Administration Approves Saxagliptin (Onglyza) for Type 2...
Yesterday, July 31, 2009, the FDA approved use of saxagliptin, a DPP4 inhibitor, in adults with type 2 diabetes as an adjunct to diet and exercise. Bristol-Myers Squibb and AstraZeneca will sell the...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Which Drug Is Best for Treatment of Type 2 Diabetes?
Physicians now have an amazing array of drug therapies for control of type 2 diabetes. Until now, there has been no consensus as to which drugs to use, and when. The American Association of Clinical...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Drug Review: Dipeptidyl-Peptidase-4 Inhibitors (sitagliptin, saxagliptin,...
The four dipeptidyl-peptidase-4 inhibitors available in the U.S. are sitagliptin (sold as Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), and alogliptin (Nesina). Vildagliptin is available in...
View Article
More Pages to Explore .....
